LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.

Rusz Orsolya and Papp Orsolya and Vízkeleti Laura and Molnár Béla Ákos and Bende Kristóf Csaba and Lotz Gábor and Ács Balázs and Kahán Zsuzsanna and Székely Tamás and Kulka Janina and Szállási Zoltán and Tőkés Anna-Mária: LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 82 (1). pp. 139-147. ISSN 0344-5704 (2018)

[thumbnail of Rusz2018_Article_LAPTM4BGeneCopyNumberGainIsAss1.pdf]
Preview
Text
Rusz2018_Article_LAPTM4BGeneCopyNumberGainIsAss1.pdf - Published Version

Download (1MB) | Preview
Item Type: Journal Article
Journal or Publication Title: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Date: 2018
Volume: 82
Number: 1
Page Range: pp. 139-147
ISSN: 0344-5704
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3376691
DOI azonosító: https://doi.org/10.1007/s00280-018-3602-z
Date Deposited: 2019. Feb. 06. 11:59
Last Modified: 2020. May. 08. 17:07
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/14636

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year